Neoplastic Meningitis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
Condition: Leptomeningeal Metastasis Intervention: Drug: 186RNL Sponsor: Plus Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2021 Category: Research Source Type: clinical trials